(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 7.78% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Cvrx's revenue in 2026 is $61,188,000.On average, 9 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,601,932,586, with the lowest CVRX revenue forecast at $1,514,308,373, and the highest CVRX revenue forecast at $1,663,874,299. On average, 9 Wall Street analysts forecast CVRX's revenue for 2027 to be $1,773,957,378, with the lowest CVRX revenue forecast at $1,592,634,669, and the highest CVRX revenue forecast at $2,011,307,366.
In 2028, CVRX is forecast to generate $2,065,576,299 in revenue, with the lowest revenue forecast at $1,697,069,729 and the highest revenue forecast at $2,710,782,495.